The Miller Lab focuses on understanding the pathophysiology of neurodegenerative disease and developing novel therapeutics for these disorders, in particular Amyotrophic Lateral Sclerosis (ALS) and dementias associated with protein Tau. The talented team of graduate students, post-docs, instructors, and technicians provides a fun, exciting, collaborative, rewarding environment to study neurodegeneration.